Rzeszow, Poland

Natalia Krata

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Chronic Kidney Disease Diagnosis and Treatment by Natalia Krata

Introduction

Natalia Krata is an accomplished inventor based in Rzeszow, Poland. She has made significant contributions to the field of medical diagnostics, particularly in the area of chronic kidney disease (CKD) and glomerulopathy. Her innovative methods aim to improve the diagnosis and treatment of these conditions, showcasing her dedication to advancing healthcare.

Latest Patents

Natalia Krata holds a patent for a method of screening for chronic kidney disease or glomerulopathy. This method involves determining the levels of specific protein markers in urine samples, which helps assess the risk of CKD or glomerulopathy in subjects. The patent also includes methods for monitoring treatment responses and administering appropriate therapies based on the assessed risks. She has 1 patent related to this groundbreaking work.

Career Highlights

Throughout her career, Natalia has worked with notable institutions, including the Medical University of Warsaw and the Institute of Biochemistry and Biophysics. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of her notable coworkers include Krzysztof Mucha and Radoslaw Zagozdzon. Their collaborative efforts have further enhanced the research and development of innovative solutions for chronic kidney disease.

Conclusion

Natalia Krata's work in the diagnosis and treatment of chronic kidney disease represents a significant advancement in medical innovation. Her patented methods have the potential to improve patient outcomes and transform the way these conditions are managed.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…